Description
These Guiding Principles provide a principles based high level framework outlining national objectives to assist medicines governance committees, including Drugs and Therapeutics Committees (DTCs), to assess and make good decisions about the quality use of high‑cost medicines. In addition, a recommendation for the future management of high-cost medicines by jurisdictions, area health service and local hospital and health service organisations has been made.
See the presentation on these Guiding Principles from the HTAi Annual Meeting 2023 in Adelaide.